The Gut-Liver Axis in Pediatric Liver Health and Disease

被引:9
|
作者
Rager, Stephanie L. [1 ,2 ]
Zeng, Melody Y. [1 ,2 ,3 ]
机构
[1] Weill Cornell Med, Gale & Ira Drukier Inst Childrens Hlth, New York, NY 10021 USA
[2] Weill Cornell Med, Dept Pediat, New York, NY 10021 USA
[3] Weill Cornell Med, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10021 USA
关键词
gut microbiota; pediatrics; hepatobiliary disease; biliary atresia; NAFLD; IBD; PRIMARY SCLEROSING CHOLANGITIS; INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; CYSTIC-FIBROSIS; OBESE CHILDREN; EARLY-LIFE; MICROBIOTA; IMPACT; ESTABLISHMENT; COLONIZATION;
D O I
10.3390/microorganisms11030597
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
There has been growing interest in the complex host-microbe interactions within the human gut and the role these interactions play in systemic health and disease. As an essential metabolic organ, the liver is intimately coupled to the intestinal microbial environment via the portal venous system. Our understanding of the gut-liver axis comes almost exclusively from studies of adults; the gut-liver axis in children, who have unique physiology and differing gut microbial communities, remains poorly understood. Here, we provide a comprehensive overview of common pediatric hepatobiliary conditions and recent studies exploring the contributions of the gut microbiota to these conditions or changes of the gut microbiota due to these conditions. We examine the current literature regarding the microbial alterations that take place in biliary atresia, pediatric non-alcoholic fatty liver disease, Wilson's disease, cystic fibrosis, inflammatory bowel disease, and viral hepatitis. Finally, we propose potential therapeutic approaches involving modulation of the gut microbiota and the gut-liver axis to mitigate the progression of pediatric liver disease.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
    Zheng, Zhipeng
    Wang, Baohong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
    Compare, D.
    Coccoli, P.
    Rocco, A.
    Nardone, O. M.
    De Maria, S.
    Carteni, M.
    Nardone, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) : 471 - 476
  • [23] Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
    Delgado, Teresa C.
    de las Heras, Javier
    Martinez-Chantar, Maria L.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] The gut-liver axis and metabolic dysfunction-associated steatotic liver disease
    Demir, Muenevver
    Tacke, Frank
    Mueller-Schilling, Martina
    Schmid, Stephan
    GASTROENTEROLOGIE, 2025,
  • [26] Gut-Liver Axis: Role of Inflammasomes
    Bawa, Manan
    Saraswaty, Vivek A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (02) : 141 - 149
  • [27] Roles of the inflammasome in the gut-liver axis
    Wang, Junfeng
    Dong, Rui
    Zheng, Shan
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 3 - 14
  • [28] The gut-liver axis in HCV infection
    Newman, Kira L. L.
    Kamada, Nobuhiko
    NATURE MICROBIOLOGY, 2023, 8 (01) : 6 - 7
  • [29] The gut-liver axis in fatty liver disease: role played by natural products
    Ming, Zhu
    Ruishi, Xie
    Linyi, Xu
    Yonggang, Yang
    Haoming, Luo
    Xintian, Lan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] The gut–liver axis and gut microbiota in health and liver disease
    Cynthia L. Hsu
    Bernd Schnabl
    Nature Reviews Microbiology, 2023, 21 : 719 - 733